Xoma corporation

Major-Pharmaceuticals

XOMA


2200 Powell Street
Emeryville , CA 94608

Executive/
Director

Price

  • Last Close
  • $ 29.45
    $ +0.41 1.41 %
    Aug 29, 2024
  • 52-Week High/Low
  • $29.45 - $13.82
  • YTD
  • 59.2%

  • Trading Volume
  • 1,264
  • Market Cap Full
  • $ 338.3M
  • Shares Outstanding
  • 11.5M
    Nov 2, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 1.4% -41.9% 68.5% -43.2% -2.1% -5% -5.9% 34.2% 14.7% 30%
Q2 6.6% -28.7% -1.7% 6.1% 16% 4% -16.3% -20.4% -10.5% 4.4%
Q3 -80.6% -16.8% 181.1% -21.3% 23.2% 8% -28.5% -19.6% -25.4% -
Q4 77% -54% 80.6% -27.9% 46.6% 128.9% -14.3% 2.7% 32% -
J F M A M J J A S O N D
2024 8% 21.7% -1.1% 9.6% - - - - - - - -
2023 10.3% 4.9% -0.8% -12.9% -7.6% 11.1% -16.6% -11% 0.5% 33.8% -21.3% 24.7%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    -47%-63%-84%744%-64%119%56%-52%-12%1%59%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.19 0.13 2.30 -0.46 0.21 -0.49 -0.7 -0.32 -0.98
Q2 0.20 0.13 0.21 -0.23 -0.47 -0.33 -0.31 -0.53 -0.59
Q3 0.18 2.13 1.98 -0.55 0.2 -0.1 -0.51 -0.48 -0.60
Q4 0.26 2.89 0.16 -0.35 -0.17 1.7 2.17 -0.65 -
A 0.8 5.3 4.7 -1.6 -0.2 0.8 0.7 -2 -2.17

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 8.7 9.8 11.2 11.3 11.5
Jun 8.4 8.7 11 11.3 11.4 11.5
Sep 8.4 8.7 11 11.3 11.5 11.5
Dec 8.4 8.8 11 11.3 11.5 11.5

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - 9.7 18 5
Total Asset Turnover - 0.2 0.2 0.2 0.1
Leverage
Debt Ratio - - 0.2 0.5 0.5
Debt – Equity Ratio - - 0.2 0.6 1.2
Interest Coverage - 9 -12 2 4.3
Equity multiplier - - - - 0.1